Anti-fibrotic Potential of <i>Moringa oleifera</i> in Hepatic Fibrosis: Molecular Mechanisms and Pharmacological Evidence

Aim: The current review aims to critically analyse the antifibrotic potential of Moringa oleifera and summarise the molecular effects of the phytoconstituents of this compound on the hepatic pathways in fibrosis. Methods: The pertinent scientific literature was gathered and examined in the large electronic databases such as PubMed, Google Scholar, ScienceDirect, and Web of Science. Experimental studies that investigate the pharmacological effects of Moringa oleifera in hepatic fibrosis were chosen from peer-reviewed articles. The in vitro and in vivo research articles were all analysed with a focus on the oxidative stress markers, inflammatory mediators, signal pathways, and hepatic stellate cell activation in relation to fibrogenesis. Results: The existing preclinical research indicates ongoing availability of studies that confirm that Moringa oleifera possesses significant anti-fibrotic, anti-oxidant and anti-inflammatory properties. Its bioactive components, flavonoids, phenolic compounds, and isothiocyanates decrease oxidative stress by reducing lipid peroxidation marker malondialdehyde and also reinstating endogenous antioxidant defence systems, superoxide dismutase, catalase and glutathione systems. M. oleifera downregulates key pro-fibrotic signalling pathways at the molecular level, including TGF-?/Smad, NF-?B, and p38-MAPK. All these effects prevent hepatic stellate cell activation and reduce ?-smooth muscle actin expression and collagen deposition in the extracellular matrix. Moreover, cytokine regulation, such as TNF-?, IL-1? and IL-18, also promotes the inhibition of inflammatory reactions that cause fibrosis development. Conclusion: All in all, recent experimental data indicate that M. oleifera functions in several complementary ways to inhibit fibrogenic pathways and hepatic tissue protection. Despite its promising preclinical results that show its therapeutic benefits, these findings require further well-designed clinical studies to confirm its safety

View article page

Download PDF